change control – Page 34

Change control documentation gaps during supplier change – risk-based change impact assessment

Tackling Documentation Gaps in Change Control During Supplier Transitions In pharmaceutical manufacturing, maintaining robust change control documentation is critical, particularly when transitioning to a new supplier for raw materials. Gaps…

Supplier change not evaluated during post-approval change review – inspection questions regulators ask

Addressing Supplier Changes Not Evaluated During Post-Approval Reviews In the dynamic landscape of pharmaceutical manufacturing, managing supplier changes is critical to maintaining product integrity and compliance. A supplier change not…

Raw material change implemented without assessment during post-approval change review – preventing batch rejection and recalls

Mitigating Risks of Unassessed Raw Material Changes During Post-Approval Reviews In the pharmaceutical manufacturing landscape, the integrity of raw materials forms the backbone of quality assurance and regulatory compliance. A…

Unapproved material substitution during regulatory inspection – inspection questions regulators ask

Addressing Unapproved Material Substitutions in Pharma: A Practical Guide for Inspection Readiness Pharmaceutical manufacturing is fraught with complexities, particularly regarding raw material management. One of the most critical issues that…

Raw material change implemented without assessment during deviation investigation – CAPA to prevent repeat failures

Managing Raw Material Changes: A Playbook for Effective Deviation Investigations The pharmaceutical manufacturing landscape demands strict adherence to guidelines and regulations, particularly when it comes to handling raw materials. One…

Supplier change not evaluated during regulatory inspection – risk-based change impact assessment

Risk-Based Change Impact Assessment for Supplier Changes in Pharma Manufacturing In an environment where compliance is paramount, pharmaceutical manufacturers must remain vigilant regarding supplier changes. When a supplier change is…

Change impact underestimated during deviation investigation – risk-based change impact assessment

Strategies for Managing Underestimated Change Impact in Pharmaceutical Deviations In the fast-paced world of pharmaceutical manufacturing, effective change control practices are paramount. Deviation investigations often reveal underestimated impacts of changes,…

Raw material change implemented without assessment during post-approval change review – risk-based change impact assessment

Mitigating Risks from Unassessed Raw Material Changes Post-Approval In the pharmaceutical manufacturing landscape, compliance with regulations and rigorous documentation are paramount. A frequent challenge faced by professionals is the implementation…

Tag: change control

Change control documentation gaps during supplier change – risk-based change impact assessment

Supplier change not evaluated during post-approval change review – inspection questions regulators ask

Raw material change implemented without assessment during post-approval change review – preventing batch rejection and recalls

Unapproved material substitution during regulatory inspection – inspection questions regulators ask

Raw material change implemented without assessment during deviation investigation – CAPA to prevent repeat failures

Supplier change not evaluated during regulatory inspection – risk-based change impact assessment

Change impact underestimated during deviation investigation – risk-based change impact assessment

Raw material change implemented without assessment during post-approval change review – risk-based change impact assessment

Unapproved material substitution during regulatory inspection – CAPA to prevent repeat failures

Change impact underestimated during post-approval change review – CAPA to prevent repeat failures

Change impact underestimated during supplier change – risk-based change impact assessment

Unapproved material substitution during supplier change – preventing batch rejection and recalls